-
InDex Pharmaceuticals’ investor call at 15:00 CET on June 1
May 31, 2023 Non Regulatory
-
InDex Pharmaceuticals announces license agreement with Viatris Japan to develop and commercialize cobitolimod in Japan
May 31, 2023 Regulatory
InDex Pharmaceuticals published the interim report for Q1 2023 on May 24, 2023.
-
Interim Report Q2 2023
-
Interim Report Q3 2023
-
Year-end Report 2023